A detailed history of Schroder Investment Management Group transactions in Exact Sciences Corp stock. As of the latest transaction made, Schroder Investment Management Group holds 670,717 shares of EXAS stock, worth $39.5 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
670,717
Previous 364,391 84.07%
Holding current value
$39.5 Million
Previous $15.4 Million 196.65%
% of portfolio
0.05%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$42.43 - $70.83 $13 Million - $21.7 Million
306,326 Added 84.07%
670,717 $45.7 Million
Q2 2024

Aug 12, 2024

BUY
$41.33 - $74.26 $11.1 Million - $19.9 Million
268,409 Added 279.65%
364,391 $15.4 Million
Q1 2024

May 14, 2024

SELL
$56.27 - $73.77 $109,051 - $142,966
-1,938 Reduced 1.98%
95,982 $6.63 Million
Q4 2023

Feb 13, 2024

BUY
$59.06 - $75.72 $5.16 Million - $6.62 Million
87,445 Added 834.8%
97,920 $7.24 Million
Q3 2023

Nov 14, 2023

SELL
$65.94 - $99.04 $50,575 - $75,963
-767 Reduced 6.82%
10,475 $714,000
Q2 2023

Aug 11, 2023

SELL
$62.68 - $95.05 $57,226 - $86,780
-913 Reduced 7.51%
11,242 $1.06 Million
Q1 2023

May 11, 2023

BUY
$47.19 - $70.77 $52,003 - $77,988
1,102 Added 9.97%
12,155 $824,000
Q2 2022

Aug 11, 2022

BUY
$35.61 - $76.23 $50,103 - $107,255
1,407 Added 14.59%
11,053 $436,000
Q1 2022

May 16, 2022

BUY
$57.56 - $82.54 $182,062 - $261,074
3,163 Added 48.79%
9,646 $688,000
Q4 2021

Feb 14, 2022

BUY
$72.5 - $100.68 $44,007 - $61,112
607 Added 10.33%
6,483 $505,000
Q3 2021

Nov 12, 2021

BUY
$90.24 - $124.05 $38,622 - $53,093
428 Added 7.86%
5,876 $561,000
Q2 2021

Aug 13, 2021

BUY
$93.66 - $139.27 $115,108 - $171,162
1,229 Added 29.13%
5,448 $677,000
Q1 2021

May 17, 2021

BUY
$116.57 - $155.01 $84,746 - $112,692
727 Added 20.82%
4,219 $556,000
Q2 2020

Aug 13, 2020

BUY
$55.75 - $92.75 $29,659 - $49,343
532 Added 17.97%
3,492 $304,000
Q1 2020

May 15, 2020

BUY
$37.9 - $104.44 $112,184 - $309,142
2,960 New
2,960 $185,000
Q2 2019

Aug 08, 2019

SELL
$89.51 - $118.04 $467,958 - $617,113
-5,228 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$61.98 - $96.5 $43,262 - $67,357
-698 Reduced 11.78%
5,228 $453,000
Q4 2018

Feb 14, 2019

SELL
$56.04 - $82.66 $37,770 - $55,712
-674 Reduced 10.21%
5,926 $374,000
Q3 2018

Nov 13, 2018

BUY
$48.29 - $80.6 $318,714 - $531,960
6,600 New
6,600 $521,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.4B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.